Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate HELP Chair Watched By Device Advocates; Will Gregg Go To Budget?

This article was originally published in The Gray Sheet

Executive Summary

A potential shift in leadership of the Senate HELP Committee is unlikely to set back the device industry's legislative agenda in coming months

You may also be interested in...



Medicare Cuts Could Be On Table As Congress Prepares For 109th Session

Budget shortages could force Congress to examine state Medicaid programs that have restricted device coverage in order to balance budgets

Medicare Cuts Could Be On Table As Congress Prepares For 109th Session

Budget shortages could force Congress to examine state Medicaid programs that have restricted device coverage in order to balance budgets

Senate HELP Chair Michael Enzi?

Wyoming Republican is in line to chair the Senate Health, Education, Labor & Pensions Committee if current Chair Judd Gregg (R-N.H.) replaces Senate Budget Committee Chair Don Nickles (R-Okla.). Last October, Nickles announced he would retire at the end of 2004. Hill staffers speculate Gregg may be tapped by Republican leadership to fill Nickles' post after the November elections. If Sen. Bill Frist (R-Tenn.) remains Senate Majority Leader next term, then Enzi - who claims the longest period of uninterrupted service on the HELP Committee - would be its new chairman. Enzi's health legislative assistant is Steven Northrup, a former executive director of the Medical Device Manufacturers Association...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021158

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel